NLRP3 Inflammasome-Mediated Pyroptosis Pathway Contributes to the Pathogenesis of Candida albicans Keratitis

Huifang Lian1,2,3,4, XiaoLong Fang2,4,5, Qingyu Li1,2

  • 1Clinical College of Ophthalmology, Tianjin Medical University, Tianjin, China.

Frontiers in Medicine
|April 25, 2022
PubMed
Abstract

Insights

NLRP3 inflammasome activation and pyroptosis contribute to Candida albicans keratitis severity. Targeting this pathway may offer new treatments for fungal keratitis.

Area of Science:

  • Ophthalmology
  • Immunology
  • Microbiology

Background:

  • Fungal keratitis is a serious eye infection with unclear pathogenic mechanisms.
  • Understanding these mechanisms is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of NOD-like receptor family pyrin domain containing 3 (NLRP3) inflammasome-mediated pyroptosis in Candida albicans keratitis.
  • To explore the underlying mechanisms of NLRP3 inflammasome activation in fungal keratitis.

Main Methods:

  • Established mouse and human corneal epithelial cell models of Candida albicans keratitis.
  • Assessed gene and protein expression of NLRP3 inflammasome components and pyroptosis markers.
  • Utilized TUNEL staining for pyroptotic cell death and LDH assay for cytotoxicity.
  • Investigated the effect of NLRP3 knockdown and a potassium channel inhibitor (glyburide).

Main Results:

  • NLRP3 inflammasome components (NLRP3, CASP1, IL-1β, GSDMD) and pyroptosis markers were significantly elevated in infected corneas and corneal cells.
  • NLRP3 knockdown reduced pyroptosis and corneal inflammation.
  • Glyburide inhibited NLRP3 inflammasome activation and pyroptosis in vitro.
  • Pyroptosis and elevated NLRP3 inflammasome activation were confirmed in both in vivo and in vitro models.

Conclusions:

  • NLRP3 inflammasome activation and pyroptosis are key events in Candida albicans keratitis.
  • This NLRP3 inflammasome-dependent pathway significantly contributes to fungal keratitis pathogenesis.
  • Targeting the NLRP3 inflammasome pathway presents a potential therapeutic strategy for fungal keratitis.